| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/14/2009 | WO2009059450A1 Peptide ligand directed drug delivery |
| 05/14/2009 | WO2009059425A1 Stat3 inhibitors for the treatment of fibrosis |
| 05/14/2009 | WO2009059349A1 Sterilisation method |
| 05/14/2009 | WO2009039854A3 Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics |
| 05/14/2009 | WO2009020987A3 Process for preparation of swellable and degradable microspheres |
| 05/14/2009 | WO2009016069A4 Stable liquid pharmaceutical composition based on trazodone |
| 05/14/2009 | WO2008134478A3 Increased drug loading capacity of polymeric material |
| 05/14/2009 | WO2008132738A3 Anticancerous polymeric agents |
| 05/14/2009 | WO2008124735A3 Multi-functional polyglutamate drug carriers |
| 05/14/2009 | WO2008094659A3 Novel biomaterials for ocular drug delivery and a method for making and using same |
| 05/14/2009 | WO2008064910A9 Metastasis-specific peptides and their diagnostic and therapeutic applications |
| 05/14/2009 | WO2008063092A3 Microstructural protein preparations containing adsorbed biologically active substances and their application in medicine and cosmetics |
| 05/14/2009 | US20090124831 Lysine-d-amphetamine dimesylate; sustained release of amphetamine; Oral bioavailability of amphetamine maintained at useful doses, but bioavailability at higher dose substantially reduced; attention deficit disorder; hyperacctivity; narcolepsy; obesity; drug abuse, drug dependency |
| 05/14/2009 | US20090124709 Analytical Methods for Validating Excipient Purity |
| 05/14/2009 | US20090124708 Collagenous tissue compositions |
| 05/14/2009 | US20090124707 Nonspecific adsorption inhibitor of substance relating to living body and method for coating article |
| 05/14/2009 | US20090124706 Contact lens solution and method for hydrophilizing contact lens by using the same |
| 05/14/2009 | US20090124705 Carbon nanotube powder, carbon nanotubes, and processes for their production |
| 05/14/2009 | US20090124704 Therapeutic foam |
| 05/14/2009 | US20090124700 Administering L-lysine-d-amphetamine or salts |
| 05/14/2009 | US20090124699 Silicone Material for Releasing an Active Molecule |
| 05/14/2009 | US20090124696 Abuse-resistant amphetamine prodrugs |
| 05/14/2009 | US20090124590 Pharmaceutical composition |
| 05/14/2009 | US20090124589 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 05/14/2009 | US20090124586 Aqueous-based pharmaceutical composition |
| 05/14/2009 | US20090124547 conjugated drug comprising nerve growth factor linked to a steroid; for tissue-targeted therapy; treating pain |
| 05/14/2009 | US20090124541 Method for the recovery and application of novel human defensins as biologically active proteins for the treatment of infections and other diseases |
| 05/14/2009 | US20090124535 Viscous terpolymers as drug delivery platform |
| 05/14/2009 | US20090124534 Trehalose Click Polymers for Delivery of Biologically Active Molecules |
| 05/14/2009 | US20090123569 Coverage indicating technology for skin sealants using tannates |
| 05/14/2009 | US20090123546 Polymer-based, sustained release drug delivery system |
| 05/14/2009 | US20090123540 Sulfoalkyl ether cyclodextrin; use in pharmaceutical dosage forms as solubilizer or stabilizer |
| 05/14/2009 | US20090123530 Liposome Drug Delivery |
| 05/14/2009 | US20090123528 Transdermal delivery of beneficial substances effected by a hostile biophysical environment |
| 05/14/2009 | US20090123519 Swellable hydrogel matrix and methods |
| 05/14/2009 | US20090123508 Implantable Drug Depot for Intrathecal Drug Delivery System for Pain Management |
| 05/14/2009 | US20090123453 Pharmaceutical Preparations And Medicines Capable Of Generating, And/Or Containing, Thrombin |
| 05/14/2009 | US20090123412 Methods and compositions for stabilizing the myocardium |
| 05/14/2009 | US20090123408 Polymer And Cosmetic Preparation |
| 05/14/2009 | US20090123404 Fragrance composition |
| 05/14/2009 | US20090123398 Silicon-free hydrocarbons providing aesthetic volatility |
| 05/14/2009 | US20090123365 Multifunctional nanostructures, methods of synthesizing thereof, and methods of use thereof |
| 05/14/2009 | US20090121709 Peptide nanostructures encapsulating A foreign material and method of manufacturing same |
| 05/14/2009 | DE102007054794A1 Wässrige Eisen-Dextran-Zubereitung mit ein oder mehreren Verbindungen der para-Hydroxy-Benzoesäureester und/oder deren Salzen Aqueous iron-dextran preparation containing one or more compounds of the para-hydroxy-benzoic acid esters and / or salts thereof |
| 05/14/2009 | DE102007054049A1 System for drug transport into trypanosomal cells comprises a ktenate matrix with targeting molecules in the form of antibody Fc fragments |
| 05/14/2009 | CA2742839A1 Novel neurturin conjugates for pharmaceutical use |
| 05/14/2009 | CA2705153A1 Intranasal compositions |
| 05/14/2009 | CA2705067A1 Increase of immune response and targeting by antigens and/or drug linkage |
| 05/14/2009 | CA2704859A1 Topical treatment with dapsone in g6pd-deficient patients |
| 05/14/2009 | CA2704639A1 Dry powder formulations comprising ascorbic acid derivates |
| 05/14/2009 | CA2704236A1 Nucleic acid complex and nucleic acid delivery composition |
| 05/14/2009 | CA2704234A1 Modified recombinant factor viii and von willebrand factor and methods of use |
| 05/14/2009 | CA2703872A1 Lidocaine tape preparation |
| 05/14/2009 | CA2703000A1 Water-immiscible materials as vehicles for drug delivery |
| 05/13/2009 | EP2058754A1 Actuation indicator for a dispensing device |
| 05/13/2009 | EP2058335A1 Biocompatible three dimensional matrix for the immobilization of biological substances |
| 05/13/2009 | EP2058331A1 Sugar chain-containing albumin, production method and use thereof |
| 05/13/2009 | EP2058311A2 8-[3-amino-piperidin-1-yl]-xanthins, their production and utilisation as medicine |
| 05/13/2009 | EP2058275A1 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 05/13/2009 | EP2058011A1 Nkt cell activating gycolipids covalently bound antigens and/or drug |
| 05/13/2009 | EP2058002A1 Reconstituted respiratory syncytial virus membranes and use as respiratory syncytial virus vaccine |
| 05/13/2009 | EP2057999A2 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
| 05/13/2009 | EP2057988A1 Nail patch |
| 05/13/2009 | EP2057987A1 Pharmaceutical composition containing statin-encapsulated nanoparticle |
| 05/13/2009 | EP2057985A1 Coated tablet |
| 05/13/2009 | EP2057983A1 Compositions for the topical protection of the ocular tissues from the damaging effects of ultraviolet radiations |
| 05/13/2009 | EP2057982A1 Intranasal compositions |
| 05/13/2009 | EP2057279A2 Bisubstrate fluorescent probe binding to protein kinases |
| 05/13/2009 | EP2056878A2 Conducting polymer nanotube actuators for precisely controlled release of medicine and bioactive molecules |
| 05/13/2009 | EP2056877A2 Pharmaceutical compositions of benzodiazepines and methods of use thereof |
| 05/13/2009 | EP2056824A2 Topical ceramide compositions and methos of use |
| 05/13/2009 | EP2056796A2 Lyophilized preparation |
| 05/13/2009 | EP2056779A2 Use of a composition for skin treatment during x-ray irradiation |
| 05/13/2009 | EP2056709A1 Dual-sensitizer-containing luminescent compounds, conjugates, and uses thereof |
| 05/13/2009 | EP2056683A2 Biogenic silica from silica-containing plant material such as rice hulls |
| 05/13/2009 | EP1848804A4 Anti-muci alpha beta antibodies |
| 05/13/2009 | EP1843749B1 Controlled release compositions for interferon based on pegt/pbt block copolymers |
| 05/13/2009 | EP1753434B1 Enhanced bimatoprost ophthalmic solution |
| 05/13/2009 | EP1721610B1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 05/13/2009 | EP1429770B1 New formulations and use thereof |
| 05/13/2009 | EP1385525B1 Targeted oxidative therapeutic formulation |
| 05/13/2009 | EP1327440B1 Oral preparations with favorable disintegration characteristics |
| 05/13/2009 | EP1317536B1 Tnf receptor-like molecules and uses thereof |
| 05/13/2009 | EP1299104B1 Tamper-resistant oral opioid agonist formulations |
| 05/13/2009 | EP1261340B1 Compositions and methods for the treatment of parkinson's disease |
| 05/13/2009 | EP1232252B1 Reversibly inactivated acidified plasmin |
| 05/13/2009 | EP1178818A4 A stable composition comprising epidermal growth factor as an active ingredient |
| 05/13/2009 | CN101432422A Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| 05/13/2009 | CN101432383A Nonaqueous pressure-sensitive adhesive composition, patches and process for production of patches |
| 05/13/2009 | CN101432333A Water dispersible films for delivery of active agents to the epidermis |
| 05/13/2009 | CN101432312A Method of producing polysaccharide derivatives |
| 05/13/2009 | CN101432307A Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 05/13/2009 | CN101432025A Peptide-peptidase inhibitor conjugates and methods of using same |
| 05/13/2009 | CN101432021A Composition comprising an antigen-recognizing molecule and a lipid-based carrier |
| 05/13/2009 | CN101431995A Stable vitamin C compositions |
| 05/13/2009 | CN101431991A Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness |
| 05/13/2009 | CN101431985A Method for solubilising hydrophobic active substances in an aqueous medium |
| 05/13/2009 | CN101431959A Accelerating agent of calcium absorption |
| 05/13/2009 | CN101429260A Polymethacrylate, preparation method and application thereof |
| 05/13/2009 | CN101429240A Albumin containing sugar chain, preparation method and uses thereof |